A detailed history of Financial Perspectives, Inc transactions in Incyte Corp stock. As of the latest transaction made, Financial Perspectives, Inc holds 1,000 shares of INCY stock, worth $71,720. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$71,720
Previous $60.6 Million 9.04%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jan 09, 2024

SELL
$79.87 - $87.53 $6.41 Million - $7.03 Million
-80,270 Reduced 98.77%
1,000 $84.1 Million
Q1 2021

Jan 09, 2024

BUY
$76.02 - $100.5 $6.1 Million - $8.07 Million
80,270 Added 8027.0%
81,270 $1 Million
Q4 2019

Jan 09, 2024

BUY
$73.04 - $95.72 $73,040 - $95,720
1,000 New
1,000 $87.3 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Financial Perspectives, Inc Portfolio

Follow Financial Perspectives, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Perspectives, Inc with notifications on news.